US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn

US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn
Fisher & Paykel could pass on potential tariff costs to customers, but those options will be limited by its market postition, Craigs analysts say. (Image: Fisher & Paykel Healthcare)
Rebecca Stevenson
US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A research note by Craigs Investment Partners considered three potential tariff scenarios from the new US government under the leadership of President Donald Trump. About 40% of New Zealand Exchange-listed (NX) Fisher & Paykel Healthcare’s sales are in the US, or about 75% of its revenue. Trump has threatened to levy tariffs against imports from countries such as Mexico, Canada and China....

More Markets

NZX 50 dips despite Fletcher Building's 4.6% gain
Markets Market Close

NZX 50 dips despite Fletcher Building's 4.6% gain

Pacific Edge shares gained after it said it got a step closer to Medicare approval.

ANZ agrees to record A$240m fine for widespread misconduct
Markets

ANZ agrees to record A$240m fine for widespread misconduct

ANZ has agreed to pay the largest penalty its Australian regulator has ever issued an entity in one go, due to failings in the bank’s dealings with both the Government and its retail customers.ANZ and the Australian Securities and Investments Commission (ASIC) will ask the Federa...

Trade Window looks to boost profile with ASX listing
Markets

Trade Window looks to boost profile with ASX listing

Trade Window is moving to broaden its investor base with a secondary listing in Australia.The Auckland-based trade software firm said on Monday that with its secondary listing, it was pursuing "the goal of increasing its profile among the broad pool of investors across the Tasman...